Sarepta Therapeutics

SRPT · NASDAQ

$19.17+$1.44 (+8.12%)TodayMarket closed ·
Prev close $17.73

Who owns SRPT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 56.7% of SRPT’s shares.

  • BlackRock Institutional Trust Company, N.A.15.2%
  • State Street Investment Management (US)8.4%
  • Vanguard Portfolio Management, LLC7.9%
  • Two Sigma Investments, LP4.4%
  • Next 6 largest institutions20.7%
  • All other shareholders43.3%
Top institutional holders of SRPT
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.16.07M15.22%
State Street Investment Management (US)8.92M8.44%
Vanguard Portfolio Management, LLC8.38M7.93%
Two Sigma Investments, LP4.60M4.36%
Vanguard Capital Management, LLC4.59M4.35%
First Trust Advisors L.P.4.37M4.14%
AQR Capital Management, LLC4.33M4.10%
Barry (Richard J)3.23M3.06%
Geode Capital Management, L.L.C.2.77M2.63%
Erste Asset Management GmbH2.57M2.43%

Largest mutual fund holders

Top mutual fund holders of SRPT
HolderShares% of shares
iShares Core S&P Small-Cap ETF6.43M6.09%
First Trust NYSE Arca Biotechnology Index Fund4.78M4.53%
State Street SPDR S&P Biotech ETF4.69M4.45%
Vanguard Total Stock Market Index Fund3.19M3.02%
iShares Russell 2000 ETF2.69M2.54%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of SRPT in the last 6 months.

Latest SRPT insider transactions
InsiderTypeSharesValue
Wong Ryan Ho-YanTax withholding13.27K$294.90K
Rothfuss CristinTax withholding22.02K$489.40K
Estepan Ian MichaelTax withholding24.80K$551.03K
Rodino-Klapac LouiseTax withholding21.42K$476.02K
SEVERINO MICHAELAward2.22M—
SEVERINO MICHAELAward756.10K—
Chambers Michael AndrewAward16.88K—
Mayo StephenAward16.88K—
Boor Kathryn JeanAward16.88K—
Nicaise ClaudeAward16.88K—

Short interest

Settled Sep 30, 2026

Shares short
22.78M
Days to cover
8.62
% of shares outstanding
21.58%
Average daily volume
2.64M
Change since last report
−10.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.